Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)

SIMPLE SUMMARY: Many head-and-neck cancer patients assigned to chemoradiation cannot receive concurrent cisplatin due to impaired renal function. Carboplatin may be an alternative option. We compared the chemoradiation outcomes of 131 patients who received cisplatin vs. 45 patients who were unfit fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rades, Dirk, Zwaan, Inga, Soror, Tamer, Idel, Christian, Pries, Ralph, Bruchhage, Karl L., Hakim, Samer G., Yu, Nathan Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340068/
https://www.ncbi.nlm.nih.gov/pubmed/37444388
http://dx.doi.org/10.3390/cancers15133278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340068/
https://www.ncbi.nlm.nih.gov/pubmed/37444388
http://dx.doi.org/10.3390/cancers15133278

Ejemplares similares